EQS-AFR: Evotec SE: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements ...

BeiGene's Tevimbra approved for ESCC with chemo, Tenaya plans $52.5M offering, Evotec gets $20M from Bristol Myers Squibb, and Osivax raises €10M for flu vaccine research ...

This page uses Cookies. For proper functioning of the page Cookies are needed. You agree to using Cookies by clicking "OK". More infos can be found in our Privacy declaration . If you disagree this ...

Triggers a $20 million research payment to Evotec, enabling further development of a preclinical program in neurodegeneration ...

The collaboration has already yielded strong results, including the in-licensing of EVT8683 (now BMS-986419) by Bristol Myers Squibb in September 2021. In March 2023, the companies reaffirmed their ...

Ongoing strategic partnership advances joint pipeline in neurodegeneration researchEvotec receives a $20 million payment to further progress research HAMBURG, DE / ACCESS Newswire / March 4, 2025 / Ev ...

Ongoing strategic partnership advances joint pipeline in neurodegeneration research Evotec receives a $20 million payment to ...

This webinar will highlight how the evaluation of IS formation at the single-cell level can support the discovery of new ...

Hamburg-based biotech company Evotec SE faced market pressure on Wednesday following an unexpected leadership change in its finance department. After initially gaining 0.7 percent to reach €8.35 in ...

Laetitia Rouxel steps down as Chief Financial Officer effective 28 February 2025 Paul Hitchin appointed to succeed as Chief Financial Officer effective 1 March 2025 HAMBURG, GERMANY / ACCESS Newswire ...

Laetitia Rouxel steps down as Chief Financial Officer effective 28 February 2025 Paul Hitchin appointed to succeed as Chief ...

European markets fell on Monday as traders reacted to the results of the German federal election. The pan-European Stoxx 600 ...